We can’t show the full text here under this license. Use the link below to read it at the source.
Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine-N-Oxide
Gut bacteria influence how dietary choline is used and the buildup of a heart disease–linked compound
AI simplified
Abstract
Nine strains of gut bacteria were identified that can produce trimethylamine (TMA) from .
- TMA is produced by gut bacteria from choline and is converted to (TMAO) in the liver.
- TMAO levels in the blood correlate with the severity of atherosclerosis in humans and have been shown to worsen this condition in mice.
- In gnotobiotic mice, only those colonized with TMA-producing bacteria had detectable levels of TMAO in their serum.
- Low colonization levels of TMA-producing bacteria led to significantly reduced choline availability for the host, with greater reductions observed at higher bacterial abundances.
- These findings suggest that the gut microbiota's ability to produce TMA may influence dietary choline requirements and strategies for managing cardiovascular disease.
AI simplified
Key numbers
100-fold
Decrease in Serum Levels
Relative abundance of TMA-producing bacteria in gnotobiotic mice.
9
Nine Identified Bacterial Strains
Strains capable of converting to TMA in vitro.